‘A plate of spaghetti’: Talus Bio boasts 5,000-fold faster drug screening by skipping protein folding

Summary

Seattle-based Talus Bio has developed a technology platform that claims to enable 5,000-fold faster drug screening by bypassing traditional protein folding approaches, particularly for transcription factors and other difficult-to-target proteins.